Ghada N Farhat

Summary

Affiliation: California Pacific Medical Center
Country: USA

Publications

  1. pmc Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers
    Ghada N Farhat
    San Francisco Coordinating Center, California Pacific Medical Center Research Institute, San Francisco, CA 94107, USA
    J Natl Cancer Inst 103:562-70. 2011
  2. pmc Sex hormone levels and risk of breast cancer with estrogen plus progestin
    Ghada N Farhat
    Affiliations of authors San Francisco Coordinating Center, California Pacific Medical Center Research Institute, San Francisco, CA GNF, NP, SRC Faculty of Health Sciences, University of Balamand, Beirut, Lebanon GNF Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA RTC Division of Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA JEM Fred Hutchinson Cancer Research Center, Seattle, WA GA, AZL Department of Internal Medicine, University of California San Francisco, San Francisco, CA AH, DG Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA EV Department of Internal Medicine, University of California Davis, Sacramento, CA JSL Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA JAC Department of Internal Medicine, Ohio State University, Columbus, OH RJ Department of Preventive Medicine, Stony Brook University, Stony Brook, NY DL Department of Medicine, Emory University, Atlanta, GA LP Karmanos Cancer Institute, Wayne State University, Detroit, MI MSS
    J Natl Cancer Inst 105:1496-503. 2013

Detail Information

Publications2

  1. pmc Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers
    Ghada N Farhat
    San Francisco Coordinating Center, California Pacific Medical Center Research Institute, San Francisco, CA 94107, USA
    J Natl Cancer Inst 103:562-70. 2011
    ..Endogenous sex hormone levels are associated with risks of breast cancer overall and estrogen receptor (ER)-positive breast tumors; however, their associations with ER-negative tumors remain unclear...
  2. pmc Sex hormone levels and risk of breast cancer with estrogen plus progestin
    Ghada N Farhat
    Affiliations of authors San Francisco Coordinating Center, California Pacific Medical Center Research Institute, San Francisco, CA GNF, NP, SRC Faculty of Health Sciences, University of Balamand, Beirut, Lebanon GNF Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA RTC Division of Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA JEM Fred Hutchinson Cancer Research Center, Seattle, WA GA, AZL Department of Internal Medicine, University of California San Francisco, San Francisco, CA AH, DG Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA EV Department of Internal Medicine, University of California Davis, Sacramento, CA JSL Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA JAC Department of Internal Medicine, Ohio State University, Columbus, OH RJ Department of Preventive Medicine, Stony Brook University, Stony Brook, NY DL Department of Medicine, Emory University, Atlanta, GA LP Karmanos Cancer Institute, Wayne State University, Detroit, MI MSS
    J Natl Cancer Inst 105:1496-503. 2013
    ..Although high endogenous sex hormone levels and estrogen plus progestin (E+P) therapy are associated with increased breast cancer risk, it is unknown whether pretreatment levels of sex hormones modify E+P effect on breast cancer...